Evidence map›Paper›PMID 41122527›Full record

ArticleJournal of vitreoretinal diseases2025

The Efficacy and Safety of Intravitreal Aflibercept 8 mg in Clinical Practice.

Brandon A Bates, Hana A Mansour, Hasenin Al-Khersan, Edward Wood, Bita Momenaei, Eric Schneider, Collin J Richards, Charles DeYoung, Charles C Wykoff, Kevin Quinn and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vitreoretinal diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Brandon A BatesAustin Retina Associates, University of Texas Dell Medical School, Austin, TX, USA.ORCID https://orcid.org/0000-0002-8702-8043
Hana A MansourThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0003-0634-3429
Hasenin Al-KhersanRetina Consultants of Texas, Houston, TX, USA.
Edward WoodAustin Retina Associates, University of Texas Dell Medical School, Austin, TX, USA.
Bita MomenaeiThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-5435-7369
Eric SchneiderTennessee Retina, Nashville, Tennessee, USA.
Collin J RichardsThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.
Charles DeYoungThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.
Charles C WykoffRetina Consultants of Texas, Houston, TX, USA.
Kevin QuinnRetina Consultants of America, Fort Worth, TX, USA.
Jason HsuThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-2761-4219
Carl D RegilloThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.
Allen C HoThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.
Mitchell S FinemanThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.
Michael A KlufasThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Philadelphia, PA, USA.
Philip P StoreyAustin Retina Associates, University of Texas Dell Medical School, Austin, TX, USA.ORCID https://orcid.org/0000-0003-2137-7387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

aflibercept 8 mgclinical practicereal worldsafetytreatment intervalsvisual outcomes

Identifiers

PMID41122527
PMCPMC12536006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.